Literature DB >> 27321185

USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability.

M Jeong1, E-W Lee1, D Seong1, J Seo1, J-H Kim1, S Grootjans2,3, S-Y Kim4, P Vandenabeele2,3, J Song1.   

Abstract

FLICE-like inhibitory protein (FLIP) is a critical regulator of death receptor-mediated apoptosis. Here, we found ubiquitin-specific peptidase 8 (USP8) to be a novel deubiquitylase of the long isoform of FLIP (FLIPL). USP8 directly deubiquitylates and stabilizes FLIPL, but not the short isoform. USP8 depletion induces FLIPL destabilization, promoting anti-Fas-, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)- and tumor necrosis factor alpha-induced extrinsic apoptosis by facilitating death-inducing signaling complex or TNFR1 complex II formation, which results in the activation of caspase-8 and caspase-3. USP8 mRNA levels are elevated in melanoma and cervical cancers, and the protein levels of USP8 and FLIPL are positively correlated in these cancer cell lines. Xenograft analyses using ME-180 cervical cancer cells showed that USP8 depletion attenuated tumor growth upon TRAIL injection. Taken together, our data indicate that USP8 functions as a novel deubiquitylase of FLIPL and inhibits extrinsic apoptosis by stabilizing FLIPL.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27321185     DOI: 10.1038/onc.2016.215

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

1.  Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development.

Authors:  W C Yeh; A Itie; A J Elia; M Ng; H B Shu; A Wakeham; C Mirtsos; N Suzuki; M Bonnard; D V Goeddel; T W Mak
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

2.  FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis.

Authors:  S M Srinivasula; M Ahmad; S Ottilie; F Bullrich; S Banks; Y Wang; T Fernandes-Alnemri; C M Croce; G Litwack; K J Tomaselli; R C Armstrong; E S Alnemri
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

3.  Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex.

Authors:  A Krueger; I Schmitz; S Baumann; P H Krammer; S Kirchhoff
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

4.  NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.

Authors:  S Kreuz; D Siegmund; P Scheurich; H Wajant
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 5.  Targeting c-FLIP in cancer.

Authors:  Sarah Shirley; Olivier Micheau
Journal:  Cancer Lett       Date:  2010-11-10       Impact factor: 8.679

6.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

7.  Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein.

Authors:  Pithi Chanvorachote; Ubonthip Nimmannit; Liying Wang; Christian Stehlik; Bin Lu; Neelam Azad; Yon Rojanasakul
Journal:  J Biol Chem       Date:  2005-10-24       Impact factor: 5.157

8.  UBPY: a growth-regulated human ubiquitin isopeptidase.

Authors:  S Naviglio; C Mattecucci; B Matoskova; T Nagase; N Nomura; P P Di Fiore; G F Draetta
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

9.  Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.

Authors:  Dohun Pyeon; Michael A Newton; Paul F Lambert; Johan A den Boon; Srikumar Sengupta; Carmen J Marsit; Craig D Woodworth; Joseph P Connor; Thomas H Haugen; Elaine M Smith; Karl T Kelsey; Lubomir P Turek; Paul Ahlquist
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

10.  Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment.

Authors:  Peter Geserick; Mike Hupe; Maryline Moulin; W Wei-Lynn Wong; Maria Feoktistova; Beate Kellert; Harald Gollnick; John Silke; Martin Leverkus
Journal:  J Cell Biol       Date:  2009-12-28       Impact factor: 10.539

View more
  20 in total

1.  K6 linked polyubiquitylation of FADD by CHIP prevents death inducing signaling complex formation suppressing cell death.

Authors:  Jinho Seo; Eun-Woo Lee; Jihye Shin; Daehyeon Seong; Young Woo Nam; Manhyung Jeong; Seon-Hyeong Lee; Cheolju Lee; Jaewhan Song
Journal:  Oncogene       Date:  2018-05-23       Impact factor: 9.867

Review 2.  The small molecule that packs a punch: ubiquitin-mediated regulation of RIPK1/FADD/caspase-8 complexes.

Authors:  Rebecca Feltham; John Silke
Journal:  Cell Death Differ       Date:  2017-06-02       Impact factor: 15.828

3.  The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells.

Authors:  Peiying Song; Songpeng Yang; Hui Hua; Hongying Zhang; Qingbin Kong; Jiao Wang; Ting Luo; Yangfu Jiang
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

4.  USP8 inhibitor-induced DNA damage activates cell cycle arrest, apoptosis, and autophagy in esophageal squamous cell carcinoma.

Authors:  Beibei Sha; Yaxin Sun; Shan Zhao; Miaomiao Li; Wenjing Huang; Zheng Li; Jianxiang Shi; Xuefei Han; Pei Li; Tao Hu; Ping Chen
Journal:  Cell Biol Toxicol       Date:  2022-01-13       Impact factor: 6.691

5.  Deubiquitylation and stabilization of Notch1 intracellular domain by ubiquitin-specific protease 8 enhance tumorigenesis in breast cancer.

Authors:  Soyeon Shin; Kyungeun Kim; Hwa-Ryeon Kim; Kris Ylaya; Sung-Im Do; Stephen M Hewitt; Hee-Sae Park; Jae-Seok Roe; Joon-Yong Chung; Jaewhan Song
Journal:  Cell Death Differ       Date:  2019-09-17       Impact factor: 15.828

6.  Expansion of DUB functionality generated by alternative isoforms - USP35, a case study.

Authors:  Pawel Leznicki; Jayaprakash Natarajan; Gerd Bader; Walter Spevak; Andreas Schlattl; Syed Arif Abdul Rehman; Deepika Pathak; Simone Weidlich; Andreas Zoephel; Marie C Bordone; Nuno L Barbosa-Morais; Guido Boehmelt; Yogesh Kulathu
Journal:  J Cell Sci       Date:  2018-05-16       Impact factor: 5.285

Review 7.  Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes.

Authors:  Hae-Seul Choi; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2022-02-03       Impact factor: 9.261

8.  ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.

Authors:  Christophe Le Clorennec; Yassamine Lazrek; Olivier Dubreuil; Carla Sampaio; Christel Larbouret; Romain Lanotte; Marie-Alix Poul; Jean-Marc Barret; Jean-François Prost; André Pèlegrin; Thierry Chardès
Journal:  Cell Commun Signal       Date:  2019-08-23       Impact factor: 5.712

9.  Down-regulation of USP8 Inhibits Cholangiocarcinoma Cell Proliferation and Invasion.

Authors:  Xu Jing; Yingjie Chen; Ye Chen; Guangyan Shi; Shuanghao Lv; Nana Cheng; Chaolin Feng; Zhen Xin; Liping Zhang; Jing Wu
Journal:  Cancer Manag Res       Date:  2020-03-24       Impact factor: 3.989

10.  Up-regulated deubiquitinase USP4 plays an oncogenic role in melanoma.

Authors:  Weinan Guo; Jinyuan Ma; Tianli Pei; Tao Zhao; Sen Guo; Xiuli Yi; Yu Liu; Shiyu Wang; Guannan Zhu; Zhe Jian; Tianwen Gao; Chunying Li; Wenjun Liao; Qiong Shi
Journal:  J Cell Mol Med       Date:  2018-03-14       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.